| Literature DB >> 33817525 |
Vera S Glukhacheva1, Sergey G Il'yasov1, Igor V Kazantsev1, Elena O Shestakova1, Dmitri S Il'yasov1, Ilia V Eltsov2, Andrey A Nefedov2,3, Yuri V Gatilov3.
Abstract
A new approach is suggested herein for the synthesis of pyrazole derivatives by reactingEntities:
Year: 2021 PMID: 33817525 PMCID: PMC8015095 DOI: 10.1021/acsomega.1c00518
Source DB: PubMed Journal: ACS Omega ISSN: 2470-1343
Scheme 1Hypothesized Scheme for the Reaction between 4-Nitrosemicarbazide (1) and Acetylacetone
Figure 1Electronic absorption spectra of starting compound 1, pyrazole 5, and the reaction product.
Scheme 2General Synthetic Protocol for 5-Hydroxy-3,5-dimethyl-2-pyrazoline (7) and Acetone Semicarbazone (9)
Scheme 3General Synthetic Protocol for 3,5-Dimethylpyrazole-1-carbohydrazide (11)
Scheme 4General Synthetic Protocols for 3,5-Dimethylpyrazole-1-carbohydrazide (11) and bis(3,5-Dimethylpyrazole-1-carbonyl)hydrazine (15)
Figure 21H assignment of NMR monitoring in CD3CN at 22 °C for 168 h: (11) 3,5-dimethylpyrazole-1-carbohydrazide (11), a precipitate containing 5 and 15.
Figure 3Molecular structure of compound 15. Thermal ellipsoids are shown at 50% probability.
Scheme 5Synthetic Scheme for bis(3,5-Dimethylpyrazole-1-carbonyl)hydrazine (15) and 1-Anilinocarbonyl-3,5-dimethylpyrazole (19)
PASS-Predicted Pharmacological Activities
| pharmacological activity score | |||||||
|---|---|---|---|---|---|---|---|
| activity | |||||||
| stroke treatment | |||||||
| anticonvulsant | 0.359 | 0.734 | 0.644 | 0.570 | 0.543 | ||
| antimitotic | 0.775 | ||||||
| leukopoiesis stimulant | 0.419 | 0.621 | 0.589 | 0.605 | 0.569 | 0.419 | 0.520 |
| antimetastatic | |||||||